Howard Marks's position in Core Scientific is currently worth $86.2M. That's 2.61% of their equity portfolio (12th largest holding). The investor owns 1.50% of the outstanding Core Scientific stock. Howard Marks started to build up the position in Core Scientific in Q3 2025 and continued to invest until Q1 2026. Since then they sold 4.36M shares. The stake costed the investor $77.9M, netting the investor a gain of 11% so far.